Skip to content
Disclosery

ABG-WTT Global Life Science Capital Partners GP Ltd: RPID position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ABG-WTT Global Life Science Capital Partners GP Ltd on RPID, newest first. How the timeline and the estimate are built.

ABG-WTT Global Life Science Capital Partners GP Ltd held 1,848,296 RPID shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,848,296 shares
    Change vs previous 13F 0 shares

    37.39% of the 13F portfolio, value $3,197,552.

    13F-HR 0001193125-26-352439 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,848,296 shares
    Change vs previous 13F 0 shares

    34.13% of the 13F portfolio, value $4,195,632.

    13F-HR 0001193125-26-227557 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,848,296 shares
    Change vs previous 13F 0 shares

    35.62% of the 13F portfolio, value $5,360,058.

    13F-HR 0001193125-26-055042 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,848,296 shares
    Change vs previous 13F 0 shares

    33.06% of the 13F portfolio, value $6,173,309.

    13F-HR 0001193125-25-283037 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,848,296 shares
    Change vs previous 13F 0 shares

    23.83% of the 13F portfolio, value $6,376,621.

    13F-HR 0000950123-25-008425 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,848,296 shares
    Change vs previous 13F +810,000 shares

    12.73% of the 13F portfolio, value $4,879,501.

    13F-HR 0000950123-25-005578 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,038,296 shares
    Change vs previous 13F 0 shares

    2.14% of the 13F portfolio, value $934,466.

    13F-HR 0000950123-25-002368 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,038,296 shares
    Change vs previous 13F not available

    4.59% of the 13F portfolio, value $924,083.

    13F-HR 0000950123-24-011466 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).